Jove
Visualize
Contact Us

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

111
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
111
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

471
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
471
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.0K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

13.9K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
13.9K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.3K
Cancer Prevention02:59

Cancer Prevention

7.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Cholesterol, Primary And Secondary Prevention, And All-cause Mortality.
  1. Home
  2. Cholesterol, Primary And Secondary Prevention, And All-cause Mortality.

Related Experiment Video

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

6.4K

Cholesterol, primary and secondary prevention, and all-cause mortality.

M H Criqui1

  • 1Department of Community and Family Medicine, University of California, San Diego, La Jolla 92093.

Annals of Internal Medicine
|December 15, 1991

View abstract on PubMed

Summary
This summary is machine-generated.

Cholesterol lowering effectively reduces coronary events in both primary and secondary prevention. However, primary prevention trials show no overall mortality benefit, possibly due to non-coronary deaths.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.6K

Related Experiment Videos

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

6.4K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.6K

Area of Science:

  • Cardiovascular Medicine
  • Preventive Cardiology
  • Clinical Trials

Background:

  • Clinical trials consistently demonstrate cholesterol lowering reduces coronary events.
  • Primary prevention trials show limited impact on total mortality, with concerns about non-coronary deaths.
  • Secondary prevention trials offer clearer benefits due to higher coronary heart disease event rates.

Purpose of the Study:

  • To investigate the link between cholesterol lowering and non-coronary causes of death.
  • To analyze existing data using dose-response methods for both individual studies and meta-analyses.
  • To inform the development of safer and more effective coronary heart disease prevention strategies.

Main Methods:

  • Review and analysis of data from clinical trials on cholesterol lowering.
  • Dose-response analyses to explore relationships between cholesterol levels and mortality.
  • Aggregate meta-analysis of individual study data.
  • Main Results:

    • Cholesterol lowering significantly decreases nonfatal and fatal coronary events.
    • Primary prevention trials show no significant reduction in total mortality.
    • A higher incidence of non-coronary deaths is observed in primary prevention treatment groups.

    Conclusions:

    • Secondary prevention trials provide stronger evidence for the benefits of cholesterol lowering.
    • Further investigation into cholesterol lowering's effect on non-coronary mortality is warranted.
    • Dose-response analyses are crucial for understanding and mitigating potential risks in cholesterol management.